Karyopharm Therapeutics Inc. (KPTI) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Karyopharm Therapeutics I...

    NASDAQ: KPTI · Real-Time Price · USD
    6.60
    -0.14 (-2.00%)
    At close: Sep 05, 2025, 3:59 PM
    6.50
    -1.52%
    After-hours: Sep 05, 2025, 05:07 PM EDT

    Karyopharm Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 62.48M 52.23M 135.19M 190.46M
    Short-Term Investments
    		 46.24M 139.21M 142.78M 38.16M
    Long-Term Investments
    		 308K 301K 633K 637K
    Other Long-Term Assets
    		 1.33M 1.33M n/a 27.42M
    Receivables
    		 30.77M 26.96M 47.09M 22.5M
    Inventory
    		 4.74M 3.04M 4.22M 4.11M
    Other Current Assets
    		 12.28M 12.47M 8.86M 6.35M
    Total Current Assets
    		 156.49M 233.92M 350.16M 275.61M
    Property-Plant & Equipment
    		 6.28M 4.88M 7.38M 1.64M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 7.93M 6.52M 8.01M 29.7M
    Total Assets
    		 164.42M 240.44M 358.17M 305.31M
    Account Payables
    		 5.11M 3.12M 2.77M 1.6M
    Deferred Revenue
    		 n/a n/a n/a 69.12M
    Short-Term Debt
    		 24.43M 3.31M 2.87M 2.32M
    Other Current Liabilities
    		 62.29M 43.23M 37.77M -21.32M
    Total Current Liabilities
    		 92.26M 69.48M 65.91M 73.72M
    Long-Term Debt
    		 162.95M 170.92M 170.1M 169.29M
    Other Long-Term Liabilities
    		 15.01M 978K 132.72M 133M
    Total Long-Term Liabilities
    		 258.17M 307.17M 308.92M 311.26M
    Total Liabilities
    		 350.44M 376.64M 374.83M 384.98M
    Total Debt
    		 194.52M 177.02M 179.07M 180.58M
    Common Stock
    		 13K 12K 12K 8K
    Retained Earnings
    		 -1.56B -1.49B -1.34B -1.18B
    Comprehensive Income
    		 -356K -161K -638K 191K
    Shareholders Equity
    		 -186.02M -136.21M -16.66M -79.67M
    Total Investments
    		 46.24M 139.21M 142.78M 38.16M

    Add to Watchlist